Building a hiPSC-based biopacemaker
Grant Award Details
Grant Type:
Grant Number:
DISC2-12263
Investigator(s):
Disease Focus:
Human Stem Cell Use:
Award Value:
$1,260,827
Status:
Closed
Progress Reports
Reporting Period:
Year 2 plus NCE
Grant Application Details
Application Title:
Building a hiPSC-based biopacemaker
Public Abstract:
Research Objective
A proof-of-concept biopacemaker constructed by bioprinting hiPSC-derived pacemaking cells and support cells based on the blueprint of the native pacemaking tissue of a large mammalian heart.
Impact
A hiPSC-based biopacemaker bioprinted using a design of the native pacemaking tissue in the heart, with protective electrical and mechanical insulations, can better sustain the pacemaking function.
Major Proposed Activities
A proof-of-concept biopacemaker constructed by bioprinting hiPSC-derived pacemaking cells and support cells based on the blueprint of the native pacemaking tissue of a large mammalian heart.
Impact
A hiPSC-based biopacemaker bioprinted using a design of the native pacemaking tissue in the heart, with protective electrical and mechanical insulations, can better sustain the pacemaking function.
Major Proposed Activities
- To make a template for bioprinting hiPSC-based biopacemaker based on the native pacemaking tissue of a large mammalian heart
- To develop two bioinks composed of hiPSC-derived cardiac cells for bioprinting biopacemakers
- To optimize the printing conditions for the bioprinter
- To characterize and assess the function of bioprinted biopacemakers
- To test the longevity of the biopacemakers subjected to cyclic stretch in a small animal
Statement of Benefit to California:
Over 350,000 patients a year in the U.S. require an electronic pacemaker to restore their heart rhythm. The annual healthcare burden amounts to $20 billion. Repeated surgeries to replace battery and electrical parts generate additional costs and suffering for patients. A bioprinted hiPSC-based biopacemaker can overcome limitations associated with electronic pacemakers, improve the quality of life for the pacemaker recipient, and reduce the cumulative health care costs.
